Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways

One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Rong, Li, Bing, Lynch, Rebecca M., Haaland, Richard E., Murphy, Megan K., Mulenga, Joseph, Allen, Susan A., Pinter, Abraham, Shaw, George M., Hunter, Eric, Robinson, James E., Gnanakaran, S., Derdeyn, Cynthia A.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741593/
https://www.ncbi.nlm.nih.gov/pubmed/19763269
http://dx.doi.org/10.1371/journal.ppat.1000594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741593/
https://www.ncbi.nlm.nih.gov/pubmed/19763269
http://dx.doi.org/10.1371/journal.ppat.1000594

Ejemplares similares